These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 29904241)

  • 61. Dysbiosis of human gut microbiome in young-onset colorectal cancer.
    Yang Y; Du L; Shi D; Kong C; Liu J; Liu G; Li X; Ma Y
    Nat Commun; 2021 Nov; 12(1):6757. PubMed ID: 34799562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.
    Liu W; Zhang X; Xu H; Li S; Lau HC; Chen Q; Zhang B; Zhao L; Chen H; Sung JJ; Yu J
    Gastroenterology; 2021 Jun; 160(7):2395-2408. PubMed ID: 33581124
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
    Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
    Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The significance of appendectomy in the context of colorectal cancer: impacts on gut microbiota and beyond.
    Lin Y; Li T
    Rev Esp Enferm Dig; 2024 Apr; 116(4):224-225. PubMed ID: 37114400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.
    Xi Y; Yuefen P; Wei W; Quan Q; Jing Z; Jiamin X; Shuwen H
    J Transl Med; 2019 Oct; 17(1):353. PubMed ID: 31665031
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fusobacterium and Enterobacteriaceae: important players for CRC?
    Allen-Vercoe E; Jobin C
    Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gut mucosal microbiome across stages of colorectal carcinogenesis.
    Nakatsu G; Li X; Zhou H; Sheng J; Wong SH; Wu WK; Ng SC; Tsoi H; Dong Y; Zhang N; He Y; Kang Q; Cao L; Wang K; Zhang J; Liang Q; Yu J; Sung JJ
    Nat Commun; 2015 Oct; 6():8727. PubMed ID: 26515465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gut Microbiota and Colorectal Cancer Risk Factors.
    Feizi H; Rezaee MA; Ghotaslou R; Sadrkabir M; Jadidi-Niaragh F; Gholizadeh P; Taghizadeh S; Ghanbarov K; Yousefi M; Kafil HS
    Curr Pharm Biotechnol; 2023; 24(8):1018-1034. PubMed ID: 36200153
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gut microbiome and colorectal adenomas.
    Dulal S; Keku TO
    Cancer J; 2014; 20(3):225-31. PubMed ID: 24855012
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Colorectal cancer: the facts in the case of the microbiota.
    Clay SL; Fonseca-Pereira D; Garrett WS
    J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer.
    Gao W; Gao X; Zhu L; Gao S; Sun R; Feng Z; Wu D; Liu Z; Zhu R; Jiao N
    Gut Microbes; 2023 Dec; 15(2):2245562. PubMed ID: 37635357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Microbial Biomarkers for Early Cancer Detection].
    Voigt AY; Zeller G; Bork P
    Dtsch Med Wochenschr; 2017 Feb; 142(4):267-274. PubMed ID: 28235227
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Noninvasive fecal testing for colorectal cancer.
    Zou J; Xiao Z; Wu Y; Yang J; Cui N
    Clin Chim Acta; 2022 Jan; 524():123-131. PubMed ID: 34756863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The Power of the Gut Microbiome: Exploring New Perspectives in Colorectal Cancer Therapy].
    Takeda M; Doki Y
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):608-612. PubMed ID: 39009515
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles.
    Kim DJ; Yang J; Seo H; Lee WH; Ho Lee D; Kym S; Park YS; Kim JG; Jang IJ; Kim YK; Cho JY
    Sci Rep; 2020 Feb; 10(1):2860. PubMed ID: 32071370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.